PASADENA, Calif., April 19, 2011 /PRNewswire/ -- Jacobs Engineering Group Inc. (NYSE:JEC) announced today that it received a contract from Huntsman Corporation and Zamil Group Holding Company to provide front end engineering and design (FEED) services for a Morpholine and Diglycolamine® Agent (DGA®) unit located in Jubail, Saudi Arabia.
Officials did not disclose the contract value, however noted that Jacobs is executing the project from its offices in Houston, Al-Khobar, Saudi Arabia, and Mumbai, India.
The commercial unit is expected to expand production of Morpholine and DGA on an annual basis, making Huntsman the largest global supplier of Morpholine and DGA. The FEED stage is expected to be complete by the third quarter of 2011. Initial production is slated for 2014.
In making the announcement, Jacobs Group Vice President Mike Autrey stated, "We are delighted to grow our relationship with Huntsman and Zamil in their joint effort to expand investment in the Middle East and support production of high value-added chemicals."
Jacobs is one of the world's largest and most diverse providers of technical, professional, and construction services.
Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2010 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.
For additional information contact: Michelle Jones 626.578.6968